Live tape
Top 8, mentions 7d6,968META1,793 mentions▲ +0.06GOOGL1,433 mentions▲ +0.03NVDA885 mentions▲ +0.09TSLA655 mentions▲ +0.05MSFT580 mentions▲ +0.06SPY571 mentions▲ +0.03AMZN554 mentions▲ +0.04AAPL497 mentions▲ +0.07

Equity · Healthcare

VCYT

NASDAQ

Veracyte, Inc.

$59.12 +0.19% vs prior close Finazon · prior-day close, indicative (IEX-derived, not the official close) · Jul 17, 2026
Price · Chart
Our own end-of-day closes 11 sessions
$60 $54 2 Jul 17 Jul

The line runs $57.09 on 2 July through $59.12 on 17 July, on a scale from $54 to $60. Days the market did not trade hold the previous close, flat.

Track this symbol on TradingView

The chart above plots the price of VCYT over the range selected — one day to the full history — drawn by TradingView from their own data. Our own licensed end-of-day series holds 11 sessions over that window: $57.09 on 2 July 2026 through $59.12 on 17 July 2026.

Market cap $4.8B
P/E (TTM) 42.2
52-week range $23.01 – $60.51
Avg volume 257.8K

Finazon · prior-day close, indicative (IEX-derived, not the official close) · valuation computed from SEC EDGAR filings · as of Jul 17, 2026

VCYT insider trades

SEC Form 4 · last 90 days · newest reported trade 21 Sep 2026
Open-market buys 0
Open-market sells 6
Net sold $1.31M
Non-trade filings 6
Date Insider Type Shares Value
21 Sep 2026 Leite John Global Chief Commercial Off Sell 4,015 $161K
14 Sep 2026 Holstein Jens Director Sell 5,000 $205K
04 Sep 2026 Chambers Rebecca Chief Financial Officer Sell 3,652 $157K
04 Sep 2026 Febbo Phillip G. Chief Scientific & Med Officer Sell 13,110 $564K
04 Sep 2026 McGuire Annie EVP, General Counsel Sell 3,254 $140K
01 Sep 2026 Bhanji Muna Director Sell 1,864 $80K

Compensation mechanics Share grants, option exercises, tax withholding and transfers. They reach the same Form 4 as a trade, but they are not the insider buying or selling on the open market, so no purchase or sale value applies to them.

Date Insider Type Shares Value
02 Sep 2026 Chambers Rebecca Chief Financial Officer Tax withheld 3,603 $162K
02 Sep 2026 Febbo Phillip G. Chief Scientific & Med Officer Tax withheld 3,639 $163K
02 Sep 2026 Leite John Global Chief Commercial Off Tax withheld 3,961 $178K
02 Sep 2026 McGuire Annie EVP, General Counsel Tax withheld 3,215 $144K
02 Sep 2026 Stapley Marc Chief Executive Officer Tax withheld 8,782 $394K
02 Sep 2026 Wygant Jonathan VP, Chief Accounting Officer Tax withheld 1,361 $61K

VCYT reported financials

SEC EDGAR XBRL

VCYT reported revenue of $517.1M for the fiscal year ended 31 Dec 2025. Net income over the same period was $66.4M.

Figure Reported Period
Revenue $517.1M 31 Dec 2025 fiscal year
Net income $66.4M 31 Dec 2025 fiscal year
Diluted EPS $0.82 31 Dec 2025 fiscal year
Total assets $1.5B 30 Jun 2026 at period end
Total equity $1.4B 30 Jun 2026 at period end

Source: SEC EDGAR XBRL company facts · latest period ended 30 Jun 2026

VCYT earnings

SEC EDGAR
Date Period EPS Revenue
30 Jun 2026 Q2 2026 $0.31 —
31 Mar 2026 Q1 2026 $0.35 —
31 Dec 2025 FY 2025 $0.82 —
30 Sep 2025 Q3 2025 $0.24 —
30 Jun 2025 Q2 2025 $-0.01 —
31 Mar 2025 Q1 2025 $0.09 —
31 Dec 2024 FY 2024 $0.31 —
30 Sep 2024 Q3 2024 $0.19 —

Next report no date announced in SEC filings yet

Reported figures & scheduled dates · SEC EDGAR filings

VCYT institutional holders

SEC Form 13F

10 of the 45 institutional funds we track reported a VCYT position for the quarter ended 30 Jun 2026 — a combined $262.0M; the latest of those filings landed 02 Sep 2026.

Fund Action Shares Value
ARK Investment Management Held (±25%) −24.8% shares 2,295,951 $134.8M
Point72 Asset Management Added +52.5% shares 737,804 $43.3M
Fisher Asset Management Held (±25%) −4.8% shares 700,592 $41.1M
D. E. Shaw & Co. Added +880.3% shares 413,037 $24.3M
AQR Capital Management Added +65.7% shares 149,648 $8.8M
Millennium Management New position 71,982 $4.2M
Bridgewater Associates Trimmed −36.4% shares 58,289 $3.4M
Man Group Trimmed −87.5% shares 22,291 $1.3M
Marshall Wace Trimmed −79.1% shares 6,367 $374K
Balyasny Asset Management Trimmed −98.0% shares 5,874 $345K

Source: SEC EDGAR 13F filings

VCYT fails-to-deliver

SEC CNS data

On 11 Sep 2026, 3,492 shares of VCYT failed to deliver (about $147K).

Settlement date Shares failed Notional % of shares out
11 Sep 2026 3,492 $147K 0.004%
03 Sep 2026 4,487 $201K 0.006%
28 Aug 2026 11,043 $500K 0.014%
27 Aug 2026 5,028 $223K 0.006%
17 Aug 2026 1,018 $42K 0.001%

Source: SEC fails-to-deliver (CNS) data

Congressional trades in VCYT

STOCK Act disclosures

The most recent congressional trade disclosed in VCYT is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 12 Nov 2025.

Date Member Type Amount
12 Nov 2025 filed 15 Dec 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K
16 Jun 2025 filed 10 Jul 2025 Gilbert Ray Cisneros, Jr. house · Democrat–CA Purchase $1K–$15K
16 Oct 2023 filed 11 Nov 2023 Josh Gottheimer house · Democrat–NJ Purchase $1K–$15K
15 Sep 2023 filed 15 Oct 2023 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
10 Apr 2023 filed 19 May 2023 Daniel S. Goldman house · Democrat–NY Sale $1K–$15K
23 Dec 2020 filed 11 Jan 2021 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K
08 Dec 2020 filed 07 Jan 2021 Josh Gottheimer house · Democrat–NJ Sale $1K–$15K
29 Oct 2020 filed 05 Nov 2020 Gilbert Ray Cisneros, Jr. house · Democrat–CA Sale $1K–$15K

Source: U.S. House of Representatives financial disclosures